SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 367 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,469,000 | -12.5% | 15,016 | +35.9% | 1.61% | +76.8% |
| Q2 2019 | $1,679,000 | -28.3% | 11,050 | -23.8% | 0.91% | -58.0% |
| Q3 2018 | $2,343,000 | +57.6% | 14,508 | +29.0% | 2.16% | +48.1% |
| Q2 2018 | $1,487,000 | -31.1% | 11,249 | -61.4% | 1.46% | -45.8% |
| Q1 2018 | $2,158,000 | -10.0% | 29,133 | -32.4% | 2.70% | -17.1% |
| Q4 2017 | $2,399,000 | -49.7% | 43,125 | -59.0% | 3.26% | -41.1% |
| Q3 2017 | $4,766,000 | -11.0% | 105,066 | -33.8% | 5.53% | -12.9% |
| Q2 2017 | $5,353,000 | +107.4% | 158,810 | +82.2% | 6.35% | +76.4% |
| Q1 2017 | $2,581,000 | – | 87,180 | – | 3.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |